Attovia Therapeutics, Inc. bought ATTO
August 4, 2026 · Form 4 insider transaction
Attovia Therapeutics, Inc. bought 140,000 shares of ATTO at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
140,000
Price
$0.00
Total value
N/A
InsiderAttovia Therapeutics, Inc.
RoleOfficer, Director
CompanyATTO
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 4, 2026
Filing dateAugust 6, 2026
Shares owned after140,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.